Astec Lifesciences
BSE 533138
2 stories, newest first.
- Board meeting on 26 October 2026 to consider unaudited Q2 and H1 results
- Reply to BSE on significant increase in share volume: no developments requiring mandatory disclosure
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.